Health Care-Associated Endocarditis Caused by Staphylococcus aureus with Reduced Susceptibility to Vancomycin
Authors:
- 1 February 2008
- journal article
- case report
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 46 (2) , 810-813
Abstract
Infective endocarditis (IE) caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility (SARV) has been reported worldwide. We report the successful treatment of a pediatric patient with SARV IE and characterization of the infecting strain. The MIC of vancomycin rose from 1.5 to 2 μg/ml, and the SARV was confirmed by population analysis.Keywords
This publication has 21 references indexed in Scilit:
- Isolates with Low-Level Vancomycin Resistance Associated with Persistent Methicillin-Resistant Staphylococcus aureus BacteremiaAntimicrobial Agents and Chemotherapy, 2006
- Treatment Outcomes for Serious Infections Caused by Methicillin‐ResistantStaphylococcus aureuswith Reduced Vancomycin SusceptibilityClinical Infectious Diseases, 2004
- Clinical Features Associated with Bacteremia Due to Heterogeneous Vancomycin‐IntermediateStaphylococcus aureusClinical Infectious Diseases, 2004
- Efficacy of Linezolid Alone or in Combination with Vancomycin for Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2003
- Epidemiological and Microbiological Characterization of Infections Caused byStaphylococcus aureuswith Reduced Susceptibility to Vancomycin, United States, 1997–2001Clinical Infectious Diseases, 2003
- Linezolid for the Treatment of Multidrug‐Resistant, Gram‐Positive Infections: Experience from a Compassionate‐Use ProgramClinical Infectious Diseases, 2003
- Accessory Gene Regulator ( agr ) Locus in Geographically Diverse Staphylococcus aureus Isolates with Reduced Susceptibility to VancomycinAntimicrobial Agents and Chemotherapy, 2002
- Emergence, Mechanism, and Clinical Implications of Reduced Glycopeptide Susceptibility in Staphylococcus aureusEuropean Journal of Clinical Microbiology & Infectious Diseases, 2001
- Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistanceThe Lancet Infectious Diseases, 2001
- Efficacy of linezolid in a staphylococcal endocarditis rabbit modelJournal of Antimicrobial Chemotherapy, 2001